Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 831.69M
September 30, 2023 871.55M
June 30, 2023 942.77M
March 31, 2023 631.00M
December 31, 2022 704.96M
September 30, 2022 638.23M
June 30, 2022 701.21M
March 31, 2022 757.15M
December 31, 2021 809.18M
September 30, 2021 774.62M
June 30, 2021 784.26M
March 31, 2021 363.85M
December 31, 2020 340.40M
September 30, 2020 350.51M
June 30, 2020 385.34M
March 31, 2020 414.24M
December 31, 2019 448.63M
September 30, 2019 471.59M
June 30, 2019 253.08M
March 31, 2019 268.99M
December 31, 2018 273.91M
September 30, 2018 281.06M
Date Value
June 30, 2018 308.54M
March 31, 2018 192.24M
December 31, 2017 209.64M
September 30, 2017 138.99M
June 30, 2017 157.96M
March 31, 2017 169.64M
December 31, 2016 190.26M
September 30, 2016 213.99M
June 30, 2016 231.17M
March 31, 2016 252.60M
December 31, 2015 262.66M
September 30, 2015 286.53M
June 30, 2015 258.46M
March 31, 2015 97.60M
December 31, 2014 116.48M
September 30, 2014 128.58M
June 30, 2014 138.78M
March 31, 2014 138.90M
December 31, 2013 53.81M
September 30, 2013 58.93M
December 31, 2012 7.362M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

253.08M
Minimum
Jun 2019
942.77M
Maximum
Jun 2023
603.91M
Average
638.23M
Median
Sep 2022

Total Assets (Quarterly) Benchmarks

ProQR Therapeutics NV 152.42M
Merus NV 455.49M
argenx SE 4.542B
Pharming Group 462.85M
Pharvaris NV 440.72M

Total Assets (Quarterly) Related Metrics